Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1956 1
1958 1
1966 4
1967 3
1968 3
1969 3
1970 5
1971 2
1972 10
1973 5
1974 9
1975 17
1976 8
1977 7
1978 15
1979 13
1980 13
1981 10
1982 9
1983 12
1984 23
1985 23
1986 18
1987 28
1988 29
1989 22
1990 19
1991 23
1992 27
1993 20
1994 28
1995 29
1996 28
1997 38
1998 46
1999 47
2000 51
2001 51
2002 44
2003 47
2004 73
2005 68
2006 72
2007 70
2008 87
2009 97
2010 85
2011 112
2012 102
2013 119
2014 128
2015 139
2016 144
2017 120
2018 134
2019 121
2020 183
2021 164
2022 176
2023 129
2024 54

Text availability

Article attribute

Article type

Publication date

Search Results

2,772 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypogonadotropic hypogonadism 2 with or without anosmia"
Page 1
Clinical Management of Congenital Hypogonadotropic Hypogonadism.
Young J, Xu C, Papadakis GE, Acierno JS, Maione L, Hietamäki J, Raivio T, Pitteloud N. Young J, et al. Endocr Rev. 2019 Apr 1;40(2):669-710. doi: 10.1210/er.2018-00116. Endocr Rev. 2019. PMID: 30698671 Review.
The initiation and maintenance of reproductive capacity in humans is dependent on pulsatile secretion of the hypothalamic hormone GnRH. Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder that results from the failure of the normal episodic GnRH secret …
The initiation and maintenance of reproductive capacity in humans is dependent on pulsatile secretion of the hypothalamic hormone GnRH. Cong …
Testosterone Treatment and Fractures in Men with Hypogonadism.
Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. Snyder PJ, et al. N Engl J Med. 2024 Jan 18;390(3):203-211. doi: 10.1056/NEJMoa2308836. N Engl J Med. 2024. PMID: 38231621 Clinical Trial.
METHODS: In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of testosterone treatment in middle-aged and older men with hypogonadism, we examined the risk of clinical fracture in a time-to-even …
METHODS: In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of test …
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.
Nordenström A, Ahmed SF, van den Akker E, Blair J, Bonomi M, Brachet C, Broersen LHA, Claahsen-van der Grinten HL, Dessens AB, Gawlik A, Gravholt CH, Juul A, Krausz C, Raivio T, Smyth A, Touraine P, Vitali D, Dekkers OM. Nordenström A, et al. Eur J Endocrinol. 2022 Apr 21;186(6):G9-G49. doi: 10.1530/EJE-22-0073. Eur J Endocrinol. 2022. PMID: 35353710 Free PMC article.
The aim was to create practice guidelines for clinical assessment and puberty induction in individuals with congenital pituitary or gonadal hormone deficiency. ...Publications on the induction of puberty with follicle-stimulation hormone and human chorionic gonadotrophin i …
The aim was to create practice guidelines for clinical assessment and puberty induction in individuals with congenital pituitary or g …
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.
Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, Davey D, Dubcenco E, Fukumoto S, Garcia M, Granger CB, Kalahasti V, Khera M, Miller MG, Mitchell LM, O'Leary MP, Pencina KM, Snyder PJ, Thompson IM Jr, Travison TG, Wolski K, Nissen SE; TRAVERSE Study Investigators. Bhasin S, et al. Am Heart J. 2022 Mar;245:41-50. doi: 10.1016/j.ahj.2021.11.016. Epub 2021 Dec 4. Am Heart J. 2022. PMID: 34871580 Free article. Clinical Trial.
Neither the long-term efficacy nor safety of testosterone treatment has been studied in an adequately-powered randomized trial. METHODS: The Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVER …
Neither the long-term efficacy nor safety of testosterone treatment has been studied in an adequately-powered randomized trial …
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M. Isidori AM, et al. J Endocrinol Invest. 2022 Dec;45(12):2385-2403. doi: 10.1007/s40618-022-01859-7. Epub 2022 Aug 26. J Endocrinol Invest. 2022. PMID: 36018454 Free PMC article.
RESULTS: Clinical diagnosis of adult-onset hypogonadism should be based on a combination of clinical and biochemical parameters. ...CONCLUSIONS: TRT can improve sexual function and body composition particularly in less complicated adult and in aging subjects …
RESULTS: Clinical diagnosis of adult-onset hypogonadism should be based on a combination of clinical and biochemical pa …
Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
Yan CH, Jang SS, Lin HC, Ma Y, Khanwalkar AR, Thai A, Patel ZM. Yan CH, et al. Int Forum Allergy Rhinol. 2023 Jun;13(6):989-997. doi: 10.1002/alr.23116. Epub 2022 Dec 21. Int Forum Allergy Rhinol. 2023. PMID: 36507615 Free PMC article. Clinical Trial.
INTRODUCTION: The current study evaluated the use of platelet-rich plasma (PRP), an autologous blood product with supraphysiologic concentrations of growth factors, in the treatment of prolonged coronavirus disease 2019 (COVID-19)-related smell loss. METHODS: This multi-instituti …
INTRODUCTION: The current study evaluated the use of platelet-rich plasma (PRP), an autologous blood product with supraphysiologic concentra …
Testosterone and Male Infertility.
Ohlander SJ, Lindgren MC, Lipshultz LI. Ohlander SJ, et al. Urol Clin North Am. 2016 May;43(2):195-202. doi: 10.1016/j.ucl.2016.01.006. Epub 2016 Mar 19. Urol Clin North Am. 2016. PMID: 27132576 Review.
Hypogonadism and its therapies have a significant impact on male fertility potential. ...
Hypogonadism and its therapies have a significant impact on male fertility potential. ...
Testosterone therapy and cardiovascular diseases.
Cittadini A, Isidori AM, Salzano A. Cittadini A, et al. Cardiovasc Res. 2022 Jul 20;118(9):2039-2057. doi: 10.1093/cvr/cvab241. Cardiovasc Res. 2022. PMID: 34293112 Review.
On this background and due to direct-to-patient marketing by drug companies, we have witnessed to the widespread use of T replacement therapy without clear indications particularly in late-life onset hypogonadism. The current review will dwell upon current evidence and con …
On this background and due to direct-to-patient marketing by drug companies, we have witnessed to the widespread use of T replacement therap …
Lutropin alfa.
Dhillon S, Keating GM. Dhillon S, et al. Drugs. 2008;68(11):1529-40. doi: 10.2165/00003495-200868110-00005. Drugs. 2008. PMID: 18627209 Review.
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonadotropic hypogonadism and profound LH deficiency (<1.2 IU/L) who received subcutaneous lutropin alfa 0-225 IU/day plu …
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogo …
Why is understanding the relationship of testosterone to cardiovascular risk so important?
Yeap BB, Anawalt BD. Yeap BB, et al. Asian J Androl. 2018 Mar-Apr;20(2):107-108. doi: 10.4103/aja.aja_71_17. Asian J Androl. 2018. PMID: 29405170 Free PMC article.
Small interventional studies of T have shown favorable effects on surrogate outcome measures, but a large randomized controlled trial (RCT) with the prespecified outcome of cardiovascular events has not been performed and would be logistically demanding. ...The US T …
Small interventional studies of T have shown favorable effects on surrogate outcome measures, but a large randomized controlled tr …
2,772 results